Skip to main content
. 2020 Jun 2;9:e51260. doi: 10.7554/eLife.51260

Author response image 1. Shown are leave-one-out (LOO) log-likelihood estimates calculated for our winning model (BAYES-SMEP), the model with an additional term capturing uncertainty-based random exploration (BAYES-SMERP), and the respective alternative model formulations (‘shift’) over all drug conditions (n=31 subjects with t=3*300 trials) and once separately for each drug condition (n=31 with t=300).

Author response image 1.

All LOO estimates were divided by the total number of data points in the sample (n*t) for better comparability across the different approaches. Bayes: Bayesian learner; SM: softmax (random exploration); E: directed exploration; R: total uncertainty-based random exploration; P: perseveration.